MAGEA11 and head and neck squamous cell carcinoma: MAGE-A11 was highly expressed in esophageal squamous cell carcinoma, head and neck squamous cell carcinoma and retinoblastoma and was involved in tumour resistance, proliferation, migration and apoptosis [31–34].